Setting up urogenital Chlamydia trachomatis testing in Suriname
The overall prevalence of Chlamydia trachomatis in a high risk population in Suriname was assessed in patients visiting the Dermatology department in the period March-August 2008 (n=200).
The overall prevalence of CT was 12.5% with 14% among men and 11% among women. Extensive typing of C. trachomatis, based on the serological differentiation of antigenic epitopes on MOMP displayed a variety of at least 9 genotypes (two D-variants) of the 13 “urogenital” pathogens distinguishable in our test system.
The predominant serovars are type D/Dv (26%) and type E (26%), followed by F (17%) which is in concordance with other data regarding the percentage of urogenital syndromes caused by these serotypes.
Prevalence of High Risk Human Papilloma Virus in Cervical Cancer in Suriname
The in 2011 established laboratory method for HPV typing in Suriname enables the assessment of the distribution of high risk Human Papilloma Virus in cervical samples.
This retrospective study, carried out with all biopsies from patients diagnosed in Suriname in 2010 and 2011 with cervical cancer, will not only provide Suriname with national epidemiological HPV data, but also with scientific data to predict the expected efficacy of future HPV vaccination programs and HPV screening.